我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

动脉粥样硬化程度与患者血清中趋化素和纤连蛋白EDA水平的相关性(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2017年第3期
页码:
293-296
栏目:
临床研究
出版日期:
2017-01-25

文章信息/Info

Title:
Correlation between degree of atherosclerosis and serum levels of chemokines and EDA-fibronectin
作者:
吴 佳1; 任雨笙2; 张治宇1; 张璐定1
第二军医大学长征医院：1.贵宾诊疗科，2.心血管内科，上海 200003
Author(s):
WU Jia1;  REN Yu-sheng2;  ZHANG Zhi-yu1;  ZHANG Lu-ding1
1.Department of VIP, 2.Department of Cardiovasology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
关键词:
动脉粥样硬化; 趋化素; 纤连蛋白EDA片段
Keywords:
atherosclerosis;  chemerin;  EDA-fibronectin
分类号:
R543.5
DOI:
-
文献标识码:
A
摘要:
目的 分析动脉粥样硬化(AS)程度与患者血清中趋化素（chemerin）和纤连蛋白EDA片段（EDA-FN）水平的相关性。方法 102例颈AS患者根据病症的严重程度分为轻度AS组（轻度硬化组，颈内动脉收缩期峰值流速在125~230 cm/s，动脉内径缩小<30%）和重度AS组（重度硬化组，颈内动脉收缩期峰值流速>230 cm/s，动脉内径缩小>70%），采用ELISA方法测定患者血清中趋化素和EDA-FN的含量，并收集患者的相关临床资料。结果 重度硬化组患者血清趋化素含量和EDA-FN水平显著高于轻度硬化组（P<0.05，或P<0.01），AS程度与血清趋化素含量呈正相关(r=0．212，P<0．01)，与EDA-FN水平呈正相关(r=0．283，P<0．01)。结论 AS程度与血清中趋化素和EDA-FN水平有相关性。
Abstract:
AIM To explore the clinical significance of changes of chemerin and EDA-fibronectin (EDA-FN) in serum of patients with atherosclerosis (AS). METHODS One hundred and two AS patients were divided into severe AS group (sAS group) and mild AS group (mAS group) according to the degree of AS. Fifty healthy subjects were included as normal control group (normal group). ELISA was used to measure the contents of chemerin and EDA-FN in serum of the three groups. RESULTS Contents of chemerin and EDA-FN in serum of the sAS and mAS groups were significantly higher than those in the normal control group (P<0.05). Contents of chemerin and EDA-FN in serum of the sAS group were significantly higher than those in the mAS group (P<0.05). CONCLUSION Levels of chemerin and EDA-FN in serum of AS patients increase significantly compared with those in healthy subjects and the levels are positively correlated with the degree of AS. Detecting the contents of chemerin and EDA-FN in serum is helpful in clinical diagnosis and prognosis of AS patients.

参考文献/References

[1]Didangelos A,Yin X,Mandal K,et al.Proteomics characterization of extracellular space components in the human aorta[J].Mol Cell Proteomics,2005,9(1):2048-2062.
[2]Fisher M,Paganini-Hill A,Martin A,et al.Carotid plaque pathology:thrombosis,ulceration,and stroke pathogenesis[J].Stroke,2005,36(2):253-257.
[3]White ES,Muro AF.Fibronectin splice variants: Understanding their multiple roles in health and disease using engineered mouse models[J].IUBMB Life,2011,63(7):538-546.
[4]Maurer E,Schaff M,Receveur N,et al.Fibrillar cellular fibronectin supports efficient platelet aggregation and procoagulant activity[J].Thromb Haemost,2015,114(6):1175-1188.
[5]Yang M,Yang G,Dong J,et al.Chemerin158K protein is the dominant chemerin isoform in synovial and cerebrospinal fluids but not in plasma[J].Investig Med,2010,58(7):883-886.
[6]Goralski K,McCarthy T,Hanniman E,et al.Chemerin,a novel adipokine that regulates adipogenesis and adipocyte metabolism[J].Biol Chem,2007,282(38):28175-28188.
[7]王 君.老年颈动脉粥样硬化性疾病诊断和治疗策略[J].中华老年心脑血管病杂志,2015,17(1):109-110.
[8]Roman AA,Parlee SD,Sinal CJ.Chemerin: a potential endocrine link between obesity and type 2 diabetes[J].Endocrine,2012,42(2):243-251.
[9]李维琴，王 兴，胡晓燕，等.血清chemerin水平与代谢综合征患者合并冠心病的相关性研究[J].现代生物医学进展,2012,12 (18):3544-3546,3518.
[10]张福庄,陶 红,王永梅,等. 心外膜脂肪体积与冠状动脉粥样硬化及左心室舒张功能的相关性研究[J].心肺血管病杂志,2012,31(1):58-63.
[11]Spiroglou S,Kostopoulos C,Varakis J,et al.Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosi[J].J Atheroscler Thromb,2010,17(2):115-130.
[12]Verhagen SN,Visseren FL.Perivascular adipose tissue as a cause of atherosclerosis[J].Atherosclerosis,2011, 214(1):3-10.
[13]Castellanos M,Leira R,Serena J,et al.Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke[J].Stroke,2004,35(7):1671-1676.
[14]Kanters SD,Banga JD,Algra A,et al.Plasma levels of cellular fibronectin in diabetes[J].Diabetes Care,2001,24(2):323-327.

备注/Memo

备注/Memo:
收稿日期：2016-08-06.基金项目：上海长征医院青年启动基金项目资助（2016CZQN11） 通讯作者：任雨笙，主任医师，主要从事冠心病基础及临床研究 Email：renyusheng@gmail.com 作者简介：吴佳，主治医师，硕士 Email：175535441@qq.com
更新日期/Last Update: 2017-02-20